Pardes Biosciences

Pardes Biosciences is a clinical-stage biopharmaceutical company headquartered in Carlsbad, California. The company employs 31 individuals. Pardes Biosciences focuses on discovering and developing novel oral drug candidates, particularly for pandemic-related diseases. They leverage modern reversible-covalent chemistry in their research and development efforts. Their target market includes patients worldwide who require innovative and accessible treatment options. Pardes Biosciences distinguishes itself through its commitment to patient-centric innovation. They integrate emerging technologies like telehealth and at-home diagnostics into their approach, aiming to improve patient access and streamline the healthcare journey. For more information about Pardes Biosciences and their innovative solutions, please visit their website at pardesbio.com.